Gilead's HIV portfolio remains dominant but faces Medicare Part D pricing pressure, limiting future growth potential. New launches like Livdelzi provide growth opportunities but are unlikely to ...

John Cena's shocking heel turn at WWE Elimination Chamber 2025 has stunned fans, changing the trajectory to WrestleMania 41. Cena joined forces with The Rock and targeted his WrestleMania opponent ...

It was the Tigers' fourth tie of the spring. Because he completely shut down the Braves. Flaherty threw six innings, scattering three hits. He didn’t allow a run, didn’t walk anybody and ...

NEW YORK, March 3 (Reuters) - Gilead Sciences (GILD.O), opens new tab set aside $200 million for a potential settlement with federal prosecutors to resolve an investigation into the drugmaker's ...

Gilead said it plans to start phase 3 trials later this year. SAN FRANCISCO — New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice ...

"Crappy day," Tigers manager A.J. Hinch said. The wind was blowing out, but that’s not why the Orioles scored six against Jack Flaherty, who got the start. Need a break? Play the USA TODAY Daily ...

Advertisement Moss portrays June, or Offred, as she is called once she is forced to be a surrogate for a wealthy family under the totalitarian government known as Gilead. "We've been afraid of ...

Kennet Brysting, president of Gilead Sciences Japan, mentioned an intriguing possibility during an interview in Tokyo late last year. “I do believe that Japan could be one of the first countries ...

Cool little bonding moment? For most pitchers, sure. But not for everyone, as Skubal learned last season before Jack Flaherty’s Tigers debut. Advertisement “He looked me right in the face and ...

In recent trading, shares of Gilead Sciences Inc (Symbol: GILD) have crossed above the average analyst 12-month target price of $111.77, changing hands for $112.26/share. When a stock reaches the ...

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.